Infectious Disease Drugs: The Chinese Market

 Published On: Mar, 2017 |    No of Pages: 164 |  Published By: BCC Research-JT Gabrielsen Consulting LLC Research | Format: PDF
Request Free Sample
The Chinese infectious disease drugs market reached $32.2 billion in 2016. The market should reach $61.7 billion by 2021, growing at a compound annual growth rate (CAGR) of 13.9% from 2016 to 2021.

INTRODUCTION

STUDY GOALS AND OBJECTIVES

The Chinese infectious disease drug market is big, fast-growing and dominated by brands from outside China. This market is very important for pharmaceutical companies in North America, Europe and other developed regions that look for strong growth and high profits in the following decade. The goal of this study is to help readers achieve a comprehensive understanding of the recent advances and trends in the infectious disease drug industry and market in China. Toward this end, this report will cover drugs for different types of infectious diseases through 2021.

The report provides a comprehensive discussion of infectious disease market applications, industry structure, marketing and distribution, partnership, and companies. The report is designed to aid companies in their strategic planning efforts for accessing infectious disease drug industry opportunities in the Chinese market.

REASONS FOR DOING THE STUDY
Infectious diseases include communicable infectious diseases and noncommunicable infectious disease.

There were more than 6.4 million people who were newly reported as suffering from one of the 39 main communicable infectious diseases in China in 2015, and 16,700 people died of the diseases. The large number of patients has created great opportunities for the producers and distributors of infectious disease drugs in both China and other countries. In addition to the 39 common communicable diseases, there are other more than 100 types of communicable and noncommunicable infectious diseases in China. These diseases consume a large volume of drugs too.

This study will help pharmaceutical companies, wholesalers and distributors gain in-depth understanding on the Chinese infectious disease drug market.

SCOPE OF REPORT
The scope of the report includes infectious disease drugs applications, industries, markets and companies in China. The markets for infectious disease drugs are given for the years 2015, 2016 and 2021.

The report covers the Chinese market for both communicable and noncommunicable infectious disease drugs. In this report, communicable infectious diseases only refer to the 39 statutory communicable diseases stated by the National Health and Family Planning Commission of the People's Republic of China (NHFPC). They include viral hepatitis, pulmonary tuberculosis, syphilis, bacillary/amebic dysentery, gonorrhea, scarlet fever, brucellosis, acquired immunodeficiency syndrome (AIDS), hand-foot-and-mouth disease, infectious diarrhea, influenza, and epidemic parotitis.

In this report, China is referred to as Mainland China. It does not include Hong Kong, Macao and Taiwan. Mainland China has a total of 31 province-level regions, including 22 provinces, four province-level municipalities (cities) and five province-level autonomous regions. Important geographic markets will be discussed, including Beijing, Shanghai, Guangdong and others.

More than 100 Chinese companies in the infectious disease drug industry are profiled in this report.

INTENDED AUDIENCE
The intended audience of this report includes pharmaceutical companies, wholesalers, distributors and investors who work in or will enter the Chinese market.

METHODOLOGY
Both primary and secondary research methodologies were used in preparing this study. Estimates of current market demand are made for 2015 and are projected for the next five years from 2016 through 2021. Projections are made in terms of constant U.S. dollars (2015), unadjusted for inflation. Growth is presented in terms of a compound average annual growth rate (CAGR). Sales values are measured at end-consumer level; reasons are discussed in the report.

INFORMATION SOURCES
Information sources for this report include experts, executives, professors and officials in the Chinese infectious disease drug industry. They are from pharmaceutical companies, associations and governmental departments. Information sources for the study also include online research, patent literature, technical journals, trade magazines, governmental data, public speeches and conference papers.
Chapter- 1: INTRODUCTION 3
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
INTENDED AUDIENCE
METHODOLOGY
INFORMATION SOURCES
ANALYSTS' CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER

Chapter- 2: SUMMARY 5 $250
LARGEST AND FASTEST-GROWING MARKETS
LAWS, REGULATIONS AND TARGETS
Table Summary : VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET, BY DISEASE TYPE, THROUGH 2021
Figure Summary : VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET, BY DISEASE TYPE, 2015-2021

Chapter- 3: THE CHINESE DRUG MARKET 20     $1006
CHINESE DRUG MARKET BY SALES CHANNELS
CHINESE DRUG MARKET BY DRUG TYPE

Chapter- 4: CHINESE INFECTIOUS DISEASE DRUG MARKET BY DISEASE     16 $805
 MOST COMMON 39 COMMUNICABLE DISEASES
OTHER INFECTIOUS DISEASES
Table 17 : VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY DISEASE TYPE, THROUGH 2021
Figure 3 : VALUE OF THE CHINESE COMMUNICABLE INFECTIOUS DISEASE DRUG MARKET BY MAJOR DISEASE TYPE, 2015-2021

Chapter- 5: CHINESE INFECTIOUS DISEASE DRUG MARKET BY PRODUCTS 60 $3018
TOP 30 AND TOP 100 INFECTIOUS DISEASE DRUGS IN CHINA

Chapter- 6: CHINESE INFECTIOUS DISEASE DRUGS BY PRODUCERS 10 $503
CHINESE HOMEGROWN DRUGMAKERS
FOREIGN DRUG MARKETS IN THE CHINESE MARKET
Table 88 : VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET BY PRODUCER TYPE, THROUGH 2021
Figure 32 : VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET BY PRODUCER TYPE, 2015-2021
Table 89 : CHINESE INFECTIOUS DISEASE DRUG MARKETBY PRODUCER GROUP, 2015

Chapter- 7: THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY SALES CHANNELS  9 $453
CHINESE INFECTIOUS DISEASE DRUGS RETAIL MARKET
CHINESE HOSPITAL MARKET FOR INFECTIOUS DISEASE DRUGS
Table 102 : VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY SALES CHANNELS, THROUGH 2021
Figure 33 : VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET BY SALES CHANNELS, 2015-2021

Chapter- 8: CHINESE INFECTIOUS DISEASE DRUG MARKET BY GEOGRAPHY 12 $604
 CHINESE GEOGRAPHY
CHINESE INFECTIOUS DISEASE DRUG MARKET BY GEOGRAPHY
CHINESE INFECTIOUS DRUG MARKET BY PROVINCE

Chapter- 9: INDUSTRY STRUCTURE AND MARKET STRATEGIES     9 $453
 DRUGMAKERS
DRUG WHOLESALERS
DRUG RETAILERS
EXCLUSIVE DISTRIBUTORS
HOSPITALS
RETAILERS
END CONSUMERS
Figure 35 : DRUG SUPPLY CHAIN IN CHINA

Chapter- 10: COMPANY PROFILES 18 $905
 ANHUI BIOCHEM UNITED PHARMACEUTICAL CO. LTD.
BAYER CHINA LTD.
BEIJING TONG REN TANG
BRISTOL-MYERS SQUIBB (CHINA) INVESTMENT CO. LTD.
CHIATAI TIANQING PHARMACEUTICAL GROUP CO. LTD.
CHINA PHARMACEUTICAL UNIVERSITY PHARMACEUTICAL CO. LTD. (CPU-PHARMA)
CHONGQING KERUI PHARMACEUTICAL CO. LTD.
CHONGQING LUMMY PHARMACEUTICAL CO. LTD.
DASHENLIN
DAWNRAYS PHARMACEUTICAL (HOLDINGS) LTD.
EBANG PHARMACEUTICAL
FUJIAN COSUNTER PHARMACEUTICAL CO. LTD.
FUREN HUAIQINGTANG PHARMACEUTICAL CO. LTD.
GSK CHINA
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDING CO. LTD.
GUODA DRUGSTORE
HARBIN PHARMACEUTICAL GROUP HOLDING CO. LTD.
HUNAN QIANJIN XIANGJIANG PHARMACEUTICAL INDUSTRY CO. LTD.
HUNAN XINHUI PHARMACEUTICAL CO. LTD.
JIANGSU WUZHONG PHARMACEUTICAL GROUP CORPORATION
KELUN INDUSTRY GROUP & SICHUAN KELUN PHARMACEUTICAL CO. LTD.
LUOXIN PHARMACEUTICAL
MEDFRON
MSD CHINA
NORTH CHINA PHARMACEUTICAL GROUP
PANBIOTIC
PFIZER CHINA
QILU PHARMACEUTICAL CO. LTD.
QINGFENG PHARMACEUTICAL GROUP
REYOUNG PHARMACEUTICAL CO. LTD.
ROCHE CHINA
RUNDU PHARMA
SHANDONG LUKANG PHARMACEUTICAL CO. LTD.
SHANDONG RUNZE PHARMACEUTICAL CO. LTD.
SUMITOMO PHARMACEUTICALS (SUZHOU) CO. LTD.
TUNGSHUN PHARMACEUTICAL
WATERSTONE PHARMACEUTICALS
YONGNING PHARMA
YOUCARE PHARMACEUTICAL GROUP CO. LTD.
YUNG SHIN PHARM. IND. (KUNSHAN) CO. LTD.
ZHEJIANG HISUN PHARMACEUTICAL CO. LTD.
ZHEJIANG MEDICINE CO. LTD.
ZHIJUN PHARMACEUTICAL CO. LTD.
ZHUHAI UNITED LABORATORIES CO. LTD.

Chapter- 11: APPENDIX 2 $101
GLOSSARY

List of Tables

Summary Table : VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET, BY DISEASE TYPE, THROUGH 2021
Table 1 : VALUE OF CHINESE DRUG END-CONSUMER MARKET, BY SALES CHANNELS, THROUGH 2021
Table 2 : VALUE OF THE CHINESE DRUG MARKET BY RETAIL CHANNEL BY DRUG TYPE, THROUGH 2021
Table 3 : CHINESE RETAIL TRADITIONAL DRUGS SALES BY MAJOR DRUG TYPE, 2015
Table 4 : CHINESE RETAIL TRADITIONAL PATENT DRUG SALES BY DRUG TYPE, 2015
Table 5 : CHINESE RETAIL CHEMICAL AND BIOLOGICAL DRUG SALES BY DRUG TYPE, 2015
Table 6 : CHINESE DRUG RETAIL SALES BY RETAIL COMPANY, 2015
Table 7 : VALUE OF THE CHINESE DRUG MARKET IN HOSPITALS, BY DRUG TYPE, THROUGH 2021
Table 8 : MARKET SHARES OF CHINESE TRADITIONAL DRUGS SOLD IN HOSPITALS, BY HOSPITAL TYPE AND DRUG TYPE, 2015
Table 9 : MARKET VALUES OF CHINESE TRADITIONAL DRUGS SOLD IN HOSPITALS, BY HOSPITAL TYPE AND DRUG TYPE, 2015
Table 10 : MARKET VALUES OF CHINESE TRADITIONAL DRUGS SOLD IN HOSPITALS, BY HOSPITAL TYPE, THROUGH 2021
Table 11 : MARKET SHARES OF CHEMICAL AND BIOLOGICAL DRUGS SOLD IN HOSPITALS BY HOSPITAL TYPE AND DRUG TYPE, 2015
Table 12 : MARKET VALUE OF CHEMICAL AND BIOLOGICAL DRUGS SOLD IN HOSPITALS IN 2015 BY HOSPITAL TYPE AND DRUG TYPE
Table 13 : MARKET VALUES OF CHEMICAL AND BIOLOGICAL DRUGS SOLD IN HOSPITALS BY HOSPITAL TYPE, THROUGH 2021
Table 14 : VALUE OF THE CHINESE DRUG MARKET BY DRUG TYPE, THROUGH 2021
Table 15 : VALUE OF CHINESE TRADITIONAL DRUGS BY SALES CHANNELS THROUGH 2021
Table 16 : VALUE OF CHINESE CHEMICAL AND BIOLOGICAL DRUGS BY SALES CHANNELS, THROUGH 2021
Table 17 : VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY DISEASE TYPE, THROUGH 2021
Table 18 : VALUE OF THE CHINESE COMMUNICABLE INFECTIOUS DISEASE DRUG MARKET BY MAJOR DISEASE TYPE, THROUGH 2021
Table 19 : NUMBER OF COMMUNICABLE DISEASES BY MAJOR TYPE IN CHINA, 2015
Table 20 : NUMBER OF CHINESE CATEGORY-A COMMUNICABLE DISEASES BY MAJOR DISEASE, 2015
Table 21 : NUMBER OF CHINESE CATEGORY B COMMUNICABLE DISEASES BY MAJOR DISEASE, 2015
Table 22 : NUMBER OF CHINESE CATEGORY C COMMUNICABLE DISEASES BY MAJOR DISEASE, 2015
Table 23 : VALUE OF CHINESE VIRAL HEPATITIS DRUG MARKET BY MAJOR TYPE, 2015
Table 24 : VALUE OF CHINESE PULMONARY TUBERCULOSIS DRUG MARKET BY MAJOR TYPE, 2015
Table 25 : VALUE OF CHINESE INFECTIVE KERATITIS/CONJUNCTIVITIS DRUG MARKET BY MAJOR DRUG TYPE, 2015
Table 26 : VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY MAJOR PRODUCT, THROUGH 2021
Table 27 : VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY MAJOR PRODUCT, THROUGH 2021
Table 28 : VALUE OF CHINESE ENTECAVIR MARKET BY SALES CHANNEL, 2015
Table 29 : CHINESE ENTECAVIR MARKET BY SALES CHANNEL AND LEADING SUPPLIER, 2015
Table 30 : VALUE OF CHINESE ENTECAVIR MARKET BY PRODUCERS, 2015
Table 31 : VALUE OF CHINESE INJECTIVE PIPERACILLIN-TAZOBACTAM MARKET, BY SALES CHANNEL, 2015
Table 32 : VALUE OF CHINESE INJECTIVE MEROPENEM MARKET BY SALES CHANNEL, 2015
Table 33 : VALUE OF CHINESE MEROPENEM MARKET BY PRODUCERS, 2015
Table 34 : VALUE OF CHINESE INJECTIVE CEFPERAZONE-SULBACTAM MARKET BY SALES CHANNEL, 2015
Table 35 : VALUE OF CHINESE INJECTIVE CEFPERAZONE-SULBACTAM MARKET BY PRODUCERS, 2015
Table 36 : VALUE OF CHINESE LEVOFLOXACIN MARKET BY DRUG FORM, 2015
Table 37 : VALUE OF CHINESE INJECTIVE LEVOFLOXACIN MARKET BY SALES CHANNEL, 2015
Table 38 : VALUE OF CHINESE ORAL LEVOFLOXACIN TABLET MARKET BY SALES CHANNEL, 2015
Table 39 : VALUE OF CHINESE INJECTIVE LEVOFLOXACIN MARKET BY PRODUCERS, 2015
Table 40 : VALUE OF CHINESE INJECTIVE CEFOPERAZONE-TAZOBACTAM MARKET BY SALES CHANNEL, 2015
Table 41 : VALUE OF CHINESE CEFUROXIMEE MARKET BY PRODUCERS, 2015
Table 42 : VALUE OF CHINESE INJECTIVE CEFUROXIMEE MARKET BY SALES CHANNEL, 2015
Table 43 : VALUE OF CHINESE INJECTIVE CEFOTIAM MARKET BY SALES CHANNEL, 2015
Table 44 : VALUE OF CHINESE CEFOTIAM MARKET BY PRODUCERS, 2015
Table 45 : VALUE OF CHINESE INJECTIVE CEFATHIAMIDINE MARKET BY SALES CHANNEL, 2015
Table 46 : VALUE OF CHINESE CEFATHIAMIDINE MARKET BY PRODUCERS, 2015
Table 47 : VALUE OF CHINESE INJECTIVE IMIPENEM/CILASTATIN MARKET BY SALES CHANNEL, 2015
Table 48 : VALUE OF CHINESE IMIPENEM/CILASTATIN MARKET BY PRODUCERS, 2015
Table 49 : VALUE OF CHINESE VORICONAZOLE MARKET BY PRODUCERS, 2015
Table 50 : VALUE OF CHINESE INJECTIVE VORICONAZOLE MARKET BY SALES CHANNEL, 2015
Table 51 : VALUE OF CHINESE VORICONAZOLE MARKET BY PRODUCERS, 2015
Table 52 : VALUE OF CHINESE MOXIFLOXACIN MARKET BY PRODUCERS, 2015
Table 53 : VALUE OF CHINESE MOXIFLOXACIN MARKET BY SALES CHANNEL, 2015
Table 54 : VALUE OF CHINESE MOXIFLOXACIN MARKET BY PRODUCERS, 2015
Table 55 : VALUE OF CHINESE INJECTIVE CEFOXITIN MARKET BY SALES CHANNEL, 2015
Table 56 : VALUE OF CHINESE CEFOXITIN MARKET BY PRODUCERS, 2015
Table 57 : VALUE OF CHINESE INJECTIVE LATAMOXEF MARKET BY SALES CHANNEL, 2015
Table 58 : VALUE OF CHINESE INJECTIVE LATAMOXEF MARKET BY PRODUCERS, 2015
Table 59 : VALUE OF CHINESE INJECTIVE CEFTRIAXONE MARKET BY SALES CHANNEL, 2015
Table 60 : VALUE OF CHINESE CEFTRIAXONE MARKET BY PRODUCER, 2015
Table 61 : VALUE OF CHINESE ADEFOVIR MARKET BY SALES CHANNEL, 2015
Table 62 : CHINESE ADEFOVIR MARKET SHARE BY SALES CHANNEL AND LEADING SUPPLIER, 2015
Table 63 : VALUE OF CHINESE ADEFOVIR MARKET BY PRODUCERS, 2015
Table 64 : VALUE OF CHINESE LAMIVUDINE MARKET BY SALES CHANNEL, 2015
Table 65 : CHINESE LAMIVUDINE MARKET SHARE BY SALES CHANNEL AND LEADING SUPPLIER, 2015
Table 66 : VALUE OF CHINESE LAMIVUDINE MARKET BY PRODUCERS, 2015
Table 67 : VALUE OF CHINESE INJECTIVE CEFAZOLIN MARKET BY SALES CHANNEL, 2015
Table 68 : VALUE OF CHINESE CEFAZOLIN MARKET BY PRODUCERS, 2015
Table 69 : VALUE OF CHINESE CEFAZOLIN MARKET BY PRODUCERS, 2015
Table 70 : VALUE OF CHINESE INJECTIVE CEFTAZIDIME MARKET BY SALES CHANNEL, 2015
Table 71 : VALUE OF CHINESE CEFTAZIDIME MARKET BY PRODUCERS, 2015
Table 72 : VALUE OF CHINESE TELBIVUDINE MARKET BY SALES CHANNEL, 2015
Table 73 : VALUE OF CHINESE CEFIXIME MARKET BY DRUG FORM, 2015
Table 74 : VALUE OF CHINESE CEFIXIME MARKET BY SALES CHANNELS, 2015
Table 75 : VALUE OF CHINESE AMOXICILLIN-CLAVULANATE MARKET BY PRODUCERS, 2015
Table 76 : VALUE OF CHINESE ITRACONAZOLE MARKET BY DRUG FORMS, 2015
Table 77 : VALUE OF CHINESE ITRACONAZOLE MARKET BY SALES CHANNELS, 2015
Table 78 : VALUE OF CHINESE CEFACLOR MARKET BY DRUG FORMS, 2015
Table 79 : VALUE OF CHINESE CEFACLOR MARKET BY SALES CHANNELS, 2015
Table 80 : VALUE OF CHINESE VIDARABINE INJECTION MARKET BY SALES CHANNEL, 2015
Table 81 : CHINESE VIDARABINE MARKET SHARE BY SALES CHANNEL AND LEADING SUPPLIER, 2015
Table 82 : VALUE OF CHINESE VIDARABINE MARKET BY PRODUCERS, 2015
Table 83 : VALUE OF CHINESE VALACYCLOVIR TABLET MARKET BY SALES CHANNEL, 2015
Table 84 : VALUE OF CHINESE INJECTIVE GANCICLOVIR MARKET BY SALES CHANNEL, 2015
Table 85 : VALUE OF CHINESE INJECTIVE FOSCARNET MARKET BY SALES CHANNEL, 2015
Table 86 : VALUE OF CHINESE OSELTAMIVIR MARKET BY SALES CHANNEL, 2015
Table 87 : VALUE OF CHINESE RIBAVIRIN MARKET BY SALES CHANNEL, 2015
Table 88 : VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET BY PRODUCER TYPE, THROUGH 2021
Table 89 : CHINESE INFECTIOUS DISEASE DRUG MARKETBY PRODUCER GROUP, 2015
Table 90 : CHINESE HOMEGROWN DRUGMAKERS AND THEIR SALES IN CHINA, 2015
Table 91 : GUANGZHOU PHARMACEUTICAL'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015
Table 92 : HARBIN PHARMACEUTICAL'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015
Table 93 : NORTH CHINA PHARMACEUTICAL'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015
Table 94 : YANGTZE RIVER PHARMACEUTICAL'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015
Table 95 : CHIATAI TIANQING'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015
Table 96 : HAILINGPHARM’S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015
Table 97 : CHINESE HOMEGROWN DRUGMAKERS AND THEIR SALES IN CHINA, 2015
Table 98 : PFIZER'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015
Table 99 : GSK'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015
Table 100 : MSD'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015
Table 101 : BAYER HEALTHCARE’S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015
Table 102 : VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY SALES CHANNELS, THROUGH 2021
Table 103 : CHINESE RETAIL DRUG MARKET, BY RETAILERS, 2015
Table 104 : CHINESE RETAIL DRUG MARKET BY DRUG PRODUCT, 2015
Table 105 : CHINESE RETAIL CEFIXIME MARKET BY DRUG FORM, 2015
Table 106 : CHINESE RETAIL ENTERCAVIR MARKET BY DRUG FORM, 2015
Table 107 : CHINESE RETAIL ADEFORVIR MARKET BY DRUG FORM, 2015
Table 108 : CHINESE MARKET VALUES OF INFECTIOUS DISEASE DRUGS SOLD IN HOSPITALS BY HOSPITAL TYPE, THROUGH 2021
Table 109 : NUMBER OF HOSPITALS IN CHINA BY TYPE, 2015
Table 110 : NUMBER OF CITY AND COUNTY HOSPITALS IN CHINA BY TYPE, 2015
Table 111 : NUMBER OF CITY AND COUNTY HOSPITALS IN CHINA BY OWNERSHIP, 2015
Table 112 : NUMBER OF CITY AND COUNTY HOSPITALS IN CHINA BY TYPE, 2015
Table 113 : VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY MAJOR REGION, THROUGH 2021
Table 114 : VALUES OF THE NORTH CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021
Table 115 : VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN NORTH CHINA MARKET BY PROVINCE, 2015
Table 116 : VALUES OF THE EAST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021
Table 117 : VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN EAST CHINA MARKET BY PROVINCE, 2015
Table 118 : VALUES OF THE SOUTH CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021
Table 119 : VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN THE SOUTH CHINA MARKET BY PROVINCE, 2015
Table 120 : VALUES OF THE MIDDLE CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021
Table 121 : VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN THE MIDDLE CHINA MARKET BY PROVINCE, 2015
Table 122 : VALUES OF THE NORTHWEST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021
Table 123 : VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN THE NORTHWEST CHINA MARKET BY PROVINCE, 2015
Table 124 : VALUES OF THE SOUTHWEST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021
Table 125 : VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN THE SOUTHWEST CHINA MARKET BY PROVINCE, 2015
Table 126 : VALUES OF THE NORTHEAST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021
Table 127 : VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN THE NORTHEAST CHINA MARKET BY PROVINCE, 2015
Table 128 : VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY MAJOR PRODUCT, THROUGH 2021

List of Figures

Summary Figure : VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET, BY DISEASE TYPE, 2015-2021
Figure 1 : VALUE OF CHINESE DRUG END-CONSUMER MARKET, BY SALES CHANNELS, 2015-2021
Figure 2 : DRUG SUPPLY CHAIN IN CHINA
Figure 3 : VALUE OF THE CHINESE COMMUNICABLE INFECTIOUS DISEASE DRUG MARKET BY MAJOR DISEASE TYPE, 2015-2021
Figure 4 : VALUE OF THE CHINESE COMMUNICABLE INFECTIOUS DISEASE DRUG MARKET BY MAJOR DISEASE TYPE, 2015-2021
Figure 5 : VALUE OF THE CHINESE COMMUNICABLE INFECTIOUS DISEASE DRUG MARKET BY MAJOR DISEASE TYPE, 2015-2021
Figure 6 : VALUE OF CHINESE ENTECAVIR MARKET BY SALES CHANNEL, 2015
Figure 7 : VALUE OF CHINESE INJECTIVE PIPERACILLIN-TAZOBACTAM MARKET, BY SALES CHANNEL, 2015
Figure 8 : VALUE OF CHINESE INJECTIVE MEROPENEM MARKET BY SALES CHANNEL, 2015
Figure 9 : VALUE OF CHINESE INJECTIVE CEFPERAZONE-SULBACTAM MARKET BY SALES CHANNEL, 2015
Figure 10 : VALUE OF CHINESE INJECTIVE LEVOFLOXACIN MARKET BY SALES CHANNEL, 2015
Figure 11 : VALUE OF CHINESE INJECTIVE CEFOPERAZONE-TAZOBACTAM MARKET BY SALES CHANNEL, 2015
Figure 12 : VALUE OF CHINESE INJECTIVE CEFUROXIME MARKET BY SALES CHANNEL, 2015
Figure 13 : VALUE OF CHINESE INJECTIVE CEFOTIAM MARKET BY SALES CHANNEL, 2015
Figure 14 : VALUE OF CHINESE INJECTIVE CEFATHIAMIDINE MARKET BY SALES CHANNEL, 2015
Figure 15 : VALUE OF CHINESE INJECTIVE IMIPENEM/CILASTATIN MARKET BY SALES CHANNEL, 2015
Figure 16 : VALUE OF CHINESE INJECTIVE VORICONAZOLE MARKET BY SALES CHANNEL, 2015
Figure 17 : VALUE OF CHINESE MOXIFLOXACIN MARKET BY SALES CHANNEL, 2015
Figure 18 : VALUE OF CHINESE INJECTIVE CEFOXITIN MARKET BY SALES CHANNEL, 2015
Figure 19 : VALUE OF CHINESE INJECTIVE LATAMOXEF MARKET BY SALES CHANNEL, 2015
Figure 20 : VALUE OF CHINESE INJECTIVE CEFTRIAXONE MARKET BY SALES CHANNEL, 2015
Figure 21 : VALUE OF CHINESE ADEFOVIR MARKET BY SALES CHANNEL, 2015
Figure 22 : VALUE OF CHINESE LAMIVUDINE MARKET BY SALES CHANNEL, 2015
Figure 23 : VALUE OF CHINESE INJECTIVE CEFAZOLIN MARKET BY SALES CHANNEL, 2015
Figure 24 : VALUE OF CHINESE INJECTIVE CEFTAZIDIME MARKET BY SALES CHANNEL, 2015
Figure 25 : VALUE OF CHINESE TELBIVUDINE MARKET BY SALES CHANNEL, 2015
Figure 26 : VALUE OF CHINESE VIDARABINE MARKET BY SALES CHANNEL, 2015
Figure 27 : VALUE OF CHINESE VALACYCLOVIR MARKET BY SALES CHANNEL, 2015
Figure 28 : VALUE OF CHINESE GANCICLOVIR MARKET BY SALES CHANNEL, 2015
Figure 29 : VALUE OF CHINESE FOSCARNET MARKET BY SALES CHANNEL, 2015
Figure 30 : VALUE OF CHINESE OSELTAMIVIR MARKET BY SALES CHANNEL, 2015
Figure 31 : VALUE OF CHINESE RIBAVIRIN MARKET BY SALES CHANNEL, 2015
Figure 32 : VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET BY PRODUCER TYPE, 2015-2021
Figure 33 : VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET BY SALES CHANNELS, 2015-2021
Figure 34 : VALUE OF THE CHINESE COMMUNICABLE INFECTIOUS DISEASE DRUG MARKET BY MAJOR REGION, 2015-2021
Figure 35 : DRUG SUPPLY CHAIN IN CHINA

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.